Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post‐hoc analysis of the EXTEND study

Detalles Bibliográficos
Autores principales: Meyer, Oliver, Wong, Raymond S. M., Khelif, Abderrahim, Stankovic, Miona, Maier, Joan, Saleh, Mansoor N., Bussel, James B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290581/
https://www.ncbi.nlm.nih.gov/pubmed/34458977
http://dx.doi.org/10.1111/bjh.17800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290581/
https://www.ncbi.nlm.nih.gov/pubmed/34458977
http://dx.doi.org/10.1111/bjh.17800

Ejemplares similares